Viewing Study NCT03259503


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-01-06 @ 4:16 PM
Study NCT ID: NCT03259503
Status: COMPLETED
Last Update Posted: 2025-11-10
First Post: 2017-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module